Nomura T, Koreeda N, Yamashita F, Takakura Y, Hashida M
Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan.
Pharm Res. 1998 Jan;15(1):128-32. doi: 10.1023/a:1011921324952.
Pharmacokinetic properties of various lipid carriers (liposome and emulsions) after intratumoral injection were studied in perfusion experiments using tissue-isolated tumor preparations of Walker 256 carcinosarcoma.
Four types of lipid carriers, large emulsion (254 nm), small emulsion (85 nm), neutral liposomes (120 nm) and cationic liposomes (125 nm) were prepared. We quantified their recovery from the tumor, leakage from the tumor surface and venous outflow after intratumoral injection into perfused tissue-isolated tumors, and analyzed venous appearance curves based on a pharmacokinetic model.
In contrast to the small emulsion and neutral liposomes, which immediately appeared in the venous outflow perfusate following intratumoral injection, the appearance of the cationic liposomes and the large emulsion was highly restricted, clearly demonstrating that intratumoral clearance of these formulations can be greatly retarded by the cationic charge and large particle size, respectively. The venous appearance rate-time profiles were fitted to equations derived from a two-compartment model by nonlinear regression analysis. When the calculated parameters were compared among these four formulations, the venous appearance rate did not exhibit such a large difference; however, the rate of transfer from the injected site to the compartment which involves clearance by venous outflow was all very different.
The results of this study indicate that the determining factor which alters the pharmacokinetic properties of these lipid carriers after intratumoral injection is not the rate of transfer from the interstitial space to the vascular side but the rate of intratumoral transfer from the injection site to the well-vascularized region.
在使用沃克256癌肉瘤组织分离肿瘤制剂的灌注实验中,研究瘤内注射后各种脂质载体(脂质体和乳剂)的药代动力学特性。
制备了四种类型的脂质载体,大乳剂(254纳米)、小乳剂(85纳米)、中性脂质体(120纳米)和阳离子脂质体(125纳米)。我们对瘤内注射到灌注的组织分离肿瘤后它们从肿瘤中的回收率、从肿瘤表面的渗漏率和静脉流出量进行了量化,并基于药代动力学模型分析了静脉出现曲线。
与瘤内注射后立即出现在静脉流出灌注液中的小乳剂和中性脂质体不同,阳离子脂质体和大乳剂的出现受到高度限制,清楚地表明这些制剂的瘤内清除分别可因阳离子电荷和大粒径而大大延迟。通过非线性回归分析将静脉出现率-时间曲线拟合到由二室模型推导的方程。当比较这四种制剂的计算参数时,静脉出现率没有表现出如此大的差异;然而,从注射部位到涉及通过静脉流出清除的隔室的转移速率都非常不同。
本研究结果表明,改变这些脂质载体瘤内注射后药代动力学特性的决定因素不是从间质空间到血管侧的转移速率,而是从注射部位到血管丰富区域的瘤内转移速率。